AstraZeneca says should know if vaccine works by year-end if trials resume

article author: 
Thu, 2020-09-10 08:49

LONDON: AstraZeneca’s chief executive Pascal Soriot said on Thursday that it should know before the end of the year whether its experimental vaccine would protect people from COVID-19, if the British drugmaker is allowed to resume trials which were paused this week.
It suspended the late-stage trials after an illness in a study subject in Britain. The patient was reportedly suffering from neurological symptoms associated with a rare spinal inflammatory disorder called transverse myelitis.

Main category: 

Leave a Reply

Your email address will not be published. Required fields are marked *